Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
17, 2025-- GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available
Locations: Redondo Beach & Costa Mesa Call: (310) 464-1369
Rather than maximizing product volume, the company emphasizes testing transparency and publicly accessible third-party lab reports
All products / Type / Easy Pen Retatrutide 10mg Easy Pen Triple GLP-1/GIP/glucagon agonist weight, glycemic & metabolic research SKU: EP-RET-10-1 Format Easy Pen Dosage 0.05mg per click Capacity 10 mg Potential benefits Weight-reduction research Glycemic-control research Liver-fat & liver-health research Cardiometabolic-marker research Body-composition research Weekly subcutaneous dosing In clinical trials, Retatrutide showed among the highest weight-reduction results recorded in clinical research for a non-surgical agent, while also addressing underlying drivers of metabolic disease
This can lead to serious medical problems
This helps molds colonize in environments, including in humans
